These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 30022158)

  • 1. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
    Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
    Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.
    Mirman Z; Sasi NK; King A; Chapman JR; de Lange T
    Nat Cell Biol; 2022 Jan; 24(1):51-61. PubMed ID: 35027730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shieldin complex mediates 53BP1-dependent DNA repair.
    Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
    Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CST/Polα/primase-mediated fill-in synthesis at DSBs.
    Mirman Z; Cai S; de Lange T
    Cell Cycle; 2023 Feb; 22(4):379-389. PubMed ID: 36205622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1.
    Bakr A; Köcher S; Volquardsen J; Petersen C; Borgmann K; Dikomey E; Rothkamm K; Mansour WY
    Oncotarget; 2016 Sep; 7(36):57679-57693. PubMed ID: 27494840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
    Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
    Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small tandem DNA duplications result from CST-guided Pol α-primase action at DNA break termini.
    Schimmel J; Muñoz-Subirana N; Kool H; van Schendel R; Tijsterman M
    Nat Commun; 2021 Aug; 12(1):4843. PubMed ID: 34376693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.
    Ghezraoui H; Oliveira C; Becker JR; Bilham K; Moralli D; Anzilotti C; Fischer R; Deobagkar-Lele M; Sanchiz-Calvo M; Fueyo-Marcos E; Bonham S; Kessler BM; Rottenberg S; Cornall RJ; Green CM; Chapman JR
    Nature; 2018 Aug; 560(7716):122-127. PubMed ID: 30046110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3-RIF1 interaction critical for shieldin activity.
    Sifri C; Hoeg L; Durocher D; Setiaputra D
    EMBO Rep; 2023 Aug; 24(8):e56834. PubMed ID: 37306046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 1 acts as a RIF1 effector to suppress DSB resection prior to Shieldin action.
    Isobe SY; Hiraga SI; Nagao K; Sasanuma H; Donaldson AD; Obuse C
    Cell Rep; 2021 Jul; 36(2):109383. PubMed ID: 34260925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice.
    King A; Reichl PI; Metson JS; Parker R; Munro D; Oliveira C; Sommerova L; Becker JR; Biggs D; Preece C; Davies B; Chapman JR
    Nat Struct Mol Biol; 2024 Sep; ():. PubMed ID: 39227718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 53BP1 in end protection and DNA synthesis at DNA breaks.
    Paiano J; Zolnerowich N; Wu W; Pavani R; Wang C; Li H; Zheng L; Shen B; Sleckman BP; Chen BR; Nussenzweig A
    Genes Dev; 2021 Oct; 35(19-20):1356-1367. PubMed ID: 34503990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.
    Setiaputra D; Escribano-Díaz C; Reinert JK; Sadana P; Zong D; Callen E; Sifri C; Seebacher J; Nussenzweig A; Thomä NH; Durocher D
    Mol Cell; 2022 Apr; 82(7):1359-1371.e9. PubMed ID: 35216668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining.
    Iyer DR; Harada N; Clairmont C; Jiang L; Martignetti D; Nguyen H; He YJ; Chowdhury D; D'Andrea AD
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2214935119. PubMed ID: 36442094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.
    Barazas M; Annunziato S; Pettitt SJ; de Krijger I; Ghezraoui H; Roobol SJ; Lutz C; Frankum J; Song FF; Brough R; Evers B; Gogola E; Bhin J; van de Ven M; van Gent DC; Jacobs JJL; Chapman R; Lord CJ; Jonkers J; Rottenberg S
    Cell Rep; 2018 May; 23(7):2107-2118. PubMed ID: 29768208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shieldin and CST co-orchestrate DNA polymerase-dependent tailed-end joining reactions independently of 53BP1-governed repair pathway choice.
    King A; Reichl P; Metson JS; Parker R; Munro D; Oliveira C; Becker JR; Biggs D; Preece C; Davies B; Chapman JR
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.
    Callen E; Zong D; Wu W; Wong N; Stanlie A; Ishikawa M; Pavani R; Dumitrache LC; Byrum AK; Mendez-Dorantes C; Martinez P; Canela A; Maman Y; Day A; Kruhlak MJ; Blasco MA; Stark JM; Mosammaparast N; McKinnon PJ; Nussenzweig A
    Mol Cell; 2020 Jan; 77(1):26-38.e7. PubMed ID: 31653568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H4K20me2 distinguishes pre-replicative from post-replicative chromatin to appropriately direct DNA repair pathway choice by 53BP1-RIF1-MAD2L2.
    Simonetta M; de Krijger I; Serrat J; Moatti N; Fortunato D; Hoekman L; Bleijerveld OB; Altelaar AFM; Jacobs JJL
    Cell Cycle; 2018; 17(1):124-136. PubMed ID: 29160738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
    Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
    Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
    Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
    J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.